This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WEISSENBRUCH, M. M. v. Articles by DREXHAGE, H. Search for Related Content PubMed PubMed Citation Articles by WEISSENBRUCH, M. M. v. Articles by DREXHAGE, H.

Evidence for Existence of Immunoglobulins that Block Ovarian Granulosa Cell Growth in Vitro. A Putative Role in Resistant Ovary Syndrome?^*

MIRJAM M. van WEISSENBRUCH, ANNEMIEKE HOEK, INGRID van VLIET-BLEEKER, JOOP SCHOEMAKER and HEMMO DREXHAGE

Department of Pediatrics, Academic Hospital of the Vrije Universiteit Amsterdam, The Netherlands
Department of Obstetrics and Gynaecology, Academic Hospital of the Vrije Universiteit Amsterdam, The Netherlands
Department of Immunology, Erasmus University Rotterdam, The Netherlands

Address correspondence and requests for reprints to: A. Hoek, M.D., Department of Immunology, Erasmus University, Postbus 1783, 3000 OR Rotterdam, The Netherlands.

The sera of 26 patients with premature ovarian failure were examined in order to detect immunoglobulin-G (IgGs) that can block FSH-induced in vitro granulosa cell DNA synthesis via, a Feulgen cytochemical bioassay system. The IgGs of four patients with polycystic ovary-like disease, five postmenopausal women, and four eumenorrheic women served as controls. Ovarian growth blocking IgGs were found in 21 of the 26 premature ovarian failure (POF) cases. The few cases characterized by the absence of follicles (streak ovaries) and the controls were negative. The ovarian blocking IgGs were far more prevalent in the POF cases than anti-cytoplasmic ovarian antibodies detected by an indirect immunofluorescence assay (only one of the 26 POF patients was positive).

Our data hence confirm earlier expressed views that immune mechanisms are involved in a high proportion of patients with POF.

^* Supported by Grant 28–679–1 of the Dutch Prevention Fund.

Present address: Department of Immunology, Erasmus University, Rotterdam, The Neherlands.

Received June 12, 1990.

This article has been cited by other articles:

				R. Cervera and J. Balasch Bidirectional effects on autoimmunity and reproduction Hum. Reprod. Update, May 22, 2008; (2008) dmn013v1. [Abstract] [Full Text] [PDF]

				D. Goswami and G. S. Conway Premature ovarian failure Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410. [Abstract] [Full Text] [PDF]

				T. Forges, P. Monnier-Barbarino, G.C. Faure, and M.C. Bene Autoimmunity and antigenic targets in ovarian pathology Hum. Reprod. Update, March 1, 2004; 10(2): 163 - 175. [Abstract] [Full Text] [PDF]

				C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF]

				M. Simoni, J. Gromoll, and E. Nieschlag The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology Endocr. Rev., December 1, 1997; 18(6): 739 - 773. [Abstract] [Full Text]

				I. Schipper, F. F. G. Rommerts, P. M. ten Hacken, and B. C. J. M. Fauser Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1325 - 1331. [Abstract] [Full Text] [PDF]

				A. Hoek, J. Schoemaker, and H. A. Drexhage Premature Ovarian Failure and Ovarian Autoimmunity Endocr. Rev., February 1, 1997; 18(1): 107 - 134. [Abstract] [Full Text]